Literature DB >> 3237048

Prediction of peak oxygen consumption in obstructive airway disease.

D A Mahler1, A Harver.   

Abstract

The hypothesis of this study was that non-exercise variables can be used to reliably predict peak oxygen consumption (VO2) in patients with obstructive airway disease (OAD). We also evaluated the impact of symptoms on exercise capacity. Selected predictor variables included age, lung function, respiratory muscle strength, gas exchange, and the Baseline Dyspnea Index (BDI). In 40 patients peak VO2 was 19.9 +/- 8.7 (mean +/- SD) ml.kg-1.min-1 during progressive, incremental exercise until limited by symptoms on a cycle ergometer. Multiple regression analysis yielded three significant predictors: forced expiratory volume in one second (FEV1), age, and BDI. Peak VO2 (ml.kg-1.min-1) = 5.5 (FEV1) - 0.3 (age) + 0.8 (BDI) + 19.3 (R2 = 0.79; SEE: 4.2 ml.kg-1.min-1). Comparisons between patients who stopped exercise because of breathlessness (N = 14) and those who stopped because of leg fatigue (N = 18) showed that lung function, inspiratory muscle strength, and peak VO2 were significantly reduced in the former group compared to the latter. Peak exercise ventilation (VE)/MVV ratio was similar in the breathless (95.3 +/- 23.8%) and leg fatigue (86.8 +/- 20.3) groups, but peak heart rate (HR)/pred. HRmax ratio was significantly higher in the leg fatigue group (86.8 +/- 12.6%) than in the breathless group (75.1 +/- 8.6%) (P = 0.006). We conclude that lung function, age, and the clinical rating of breathlessness reliably predict peak VO2 in patients with symptomatic OAD. Moreover, peak exercise performance in OAD appears to be affected by different physiological factors which may be distinguished by the major symptom limiting exercise.

Entities:  

Mesh:

Year:  1988        PMID: 3237048

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Activity monitoring and energy expenditure in COPD patients: a validation study.

Authors:  Sanjay A Patel; Roberto P Benzo; William A Slivka; Frank C Sciurba
Journal:  COPD       Date:  2007-06       Impact factor: 2.409

2.  Patients' self-reports of dyspnea: An important and independent outcome in chronic obstructive pulmonary disease.

Authors:  E G Eakin; R M Kaplan; A L Ries; D E Sassi-Dambron
Journal:  Ann Behav Med       Date:  1996-06

3.  Effects of dietary carbohydrate on delayed onset muscle soreness and reactive oxygen species after contraction induced muscle damage.

Authors:  G L Close; T Ashton; T Cable; D Doran; C Noyes; F McArdle; D P M MacLaren
Journal:  Br J Sports Med       Date:  2005-12       Impact factor: 13.800

4.  Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria.

Authors:  Olga Sazonova; Venkata Manem; Chloé Béland; Marc-André Hamel; Yves Lacasse; Marie-Hélène Lévesque; Michèle Orain; David Joubert; Steeve Provencher; David Simonyan; Philippe Joubert
Journal:  JTO Clin Res Rep       Date:  2020-07-24

Review 5.  Exercise dyspnea in patients with COPD.

Authors:  Loredana Stendardi; Barbara Binazzi; Giorgio Scano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.